IP Verse

Anticancer Compositions

Patent No. EP3226842 (titled "Anticancer Compositions") was filed by Aragon Pharmaceuticals on Dec 3, 2015. The application was issued on Nov 25, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSAug 25, 2021D YOUNG
ALFRED E TIEFENBACHERAug 24, 2021HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3226842

ARAGON PHARMACEUTICALS
Application Number
EP15817642A
Filing Date
Dec 3, 2015
Status
Opposition Rejected
Mar 21, 2025
Publication Date
Nov 25, 2020
External Links
Slate, Register , Google Patents